IJMSC Editorial Board and Publishing Staff
The IJMSC editorial board is a critical resource in support of the Editor in Chief as well as the aims and scope of the journal. Members of the editorial board serve in an important advisory capacity to the Editor in Chief and the rest of the editorial team on all matters affecting the journal, and contribute reviews of manuscripts as needed. The current editorial board comprises individuals from across North America and Europe, with plans to add representation from other parts of the world as members complete their terms.
Francois Bethoux, MD
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Ohio, USA
Dr. Bethoux is Director of Rehabilitation Services at the Mellen Center for MS Treatment and Research, and Medical Director of the Arts and Medicine Institute, at the Cleveland Clinic Foundation. He is also Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Bethoux received his MD from Claude Bernard University in Lyon, France. His research interests include neurorehabilitation, spasticity management, and interventions (including therapeutic arts) to improve walking in persons with MS.
Mary Alissa Willis, MD
University of Mississippi Medical Center, Jackson, Mississippi, USA
Dr. Willis is Associate Professor and Chair of Neurology at the University of Mississippi Medical Center. She completed a clinical neuroimmunology fellowship and previously served as Medical Director at the Mellen Center for Multiple Sclerosis at Cleveland Clinic. Her specific areas of interest include medical education, spasticity management, and comprehensive care of the MS patient.
Ted Brown, MD, MPH
Evergreen Neuroscience Institute and Medical Center, Kirkland, Washington, USA
Dr. Brown is Director of Neurorehabilitation at the MS Center at Evergreen, Evergreen Hospital Medical Center, Kirkland, Washington. His clinical emphasis is on maximizing function and mobility in MS patients, and his research interests are in clinical trials and rehabilitation interventions for MS. He received his MD from Harvard University and his MPH from the University of California at Berkeley, and is certified by the American Board of Physical Medicine and Rehabilitation.
Susan Coote, PhD, PT
Clinical Therapies Department, University of Limerick, Ireland
Dr. Coote leads the MS research team at the University of Limerick, which has a focus on reducing symptoms and improving quality of life for people with MS in the community. Her research themes include exercise for falls prevention, physiotherapy interventions, physical activity programs, and technology to enhance rehabilitation. Dr. Coote graduated with a BSc in Physiotherapy from Trinity College Dublin and completed her PhD in the area of technology in stroke rehabilitation.
Mary L. Filipi, PhD, APRN
Wahoo, NE, USA
Dr. Filipi is a Nurse Practitioner in Wahoo, Nebraska. She has more than 20 years of experience in the field of MS and was previously at the MS Center of Nebraska, Lincoln, and the University of Nebraska Medical Center, Omaha. She received her PhD from the University of Nebraska Medical Center, Medical Science Intradepartmental Area in Neuroscience. Among her research interests is the impact of systemic inflammation in patients with MS.
Marcia Finlayson, PhD, OT Reg (Ont), OTR
School of Rehabilitation Therapy, Queen’s University, Kingston, Ontario, Canada
Dr. Finlayson is Director and Vice-Dean (Health Sciences), School of Rehabilitation Therapy, Queen’s University, Kingston, Ontario, Canada. Her research program focuses on developing, implementing, and evaluating self-management programs and rehabilitation services to enhance the health and well-being of people affected by MS. Her work focuses primarily on fatigue management, falls prevention, and issues related to aging with MS. She received her PhD in community health sciences from the University of Manitoba.
Frederick W. Foley, PhD
Yeshiva University, Bronx, New York, USA
Holy Name Medical Center, Teaneck, New Jersey, USA
Dr. Foley is Professor of Psychology at the Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York, and Director of Psychosocial Research and Neuropsychology at Holy Name Medical Center Multiple Sclerosis Center, Teaneck, New Jersey. His work in MS has focused on developing psychological based treatments for anxiety, depression, pain, and sexual function, and developing symptomatic screening measures. He received his PhD in clinical psychology from Fordham University.
Kathleen Fuchs, PhD, ABPP
James Q. Miller MS Clinic at University of Virginia Health System, Charlottesville, USA
Dr. Fuchs is Associate Professor of Clinical Neurology in the Department of Neurology at the University of Virginia (UVA), Charlottesville. She has been part of the UVA James Q. Miller MS Clinic since it was founded. She is board certified in clinical neuropsychology, and she does cognitive assessments of individuals with MS as well as psychotherapy. She earned her PhD at the University of Houston and completed an internship in clinical psychology at the University of Chicago Medical Center and a postdoctoral fellowship in clinical neuropsychology at UVA.
Eduard Gappmaier, PT, PhD
Department of Physical Therapy, University of Utah, Salt Lake City, USA
Dr. Gappmeier is Associate Professor and Director of the Clinical Neuromuscular Research Laboratory, Department of Physical Therapy, College of Health, University of Utah, Salt Lake City. His research focuses on the effects of physical activity on physical fitness, function, health-related quality of life, and disease progression in people with neuromuscular disease and MS. He received his PhD in exercise physiology from Brigham Young University, Provo, Utah.
Christoph Heesen, MD
Multiple Sclerosis Day Hospital, Institute of Neuroimmunology and Clinical MS Research
Department of Neurology, University Medical Center, Hamburg, Germany
Dr. Heesen is Head of the Multiple Sclerosis Day Hospital and Outpatient Unit and Deputy Head of the Institute of Neuroimmunology and Clinical MS Research, University Medical Center, Hamburg, Germany. His main research interests are psychoneuroimmunology and behavioral interventions in MS, with a special focus on shared decision making. He is an active member of Rehabilitation in Multiple Sclerosis (RIMS), the European network for best practice and research in MS rehabilitation.
James Marriott, MD, FRCPC
Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, Canada
Dr. Marriott’s research interests revolve around clinical trials to develop new disease-modifying and symptomatic therapies for MS patients. He is specifically interested in investigator-initiated trials to study novel agents to treat symptoms such as MS-related fatigue. He is also interested in clinical trial design and developing better endpoints for evaluating MS disability. In addition, he is interested in how clinical trial data are incorporated into general medical practice and the effect of therapies in real-world settings.
Lori Mayer, MSN, DNP(s), MSCN, CCRP, RN
MS Clinic of Central Texas, Round Rock, USA
Dr. Mayer is the Director of Medical Research for the MS Clinic of Central Texas (Austin area). Her responsibilities include managing MS clinical research programs and providing patient-centered care for clinical trial participants. She has written MS protocols for clinical trials and has published articles in neurologic journals. She holds a Doctor of Nursing Practice degree, is currently MS-certified, has served as past board member of the International Organization of MS Nurses (IOMSN), and is currently Research chair for the IOMSN, as well as an editor of www.LiveWiseMS.org.
Sarah A. Morrow, MD, MSc, FRCPC
Department of Clinical Neurological Sciences, Western University, London Health Sciences Centre, Ontario, Canada
Dr. Morrow is an Associate Professor of Neurology in the Department of Clinical Neurological Sciences at Western University in London, Ontario, Canada. In addition to working in the MS clinic at London Health Sciences Center, she has established the first MS cognitive clinic in Canada. Her research focuses on cognitive impairment in MS, and the use of corticosteroids for MS relapses.
Ahmed Z. Obeidat, MD, PhD
Medical College of Wisconsin, Milwaukee, WI, USA
Dr. Obeidat is Assistant Professor of Neurology at the Medical College of Wisconsin, Milwaukee, and Founding Director of the Neuroimmunology and MS Fellowship program. He received his medical degree with honors from Jordan University of Science and Technology in 2008 and a PhD in neuroscience and physiology from Wright State University, where he received the Graduate Student Excellence Award and served as a President’s Ambassador. He completed residency and fellowship training at the University of Cincinnati. Dr. Obeidat is interested in the intersection between arts, humanities, and neurology.
Jacob J. Sosnoff, PhD
University of Illinois at Urbana-Champaign, USA
Dr. Sosnoff is Associate Professor in the Department of Kinesiology and Community Health at the University of Illinois at Urbana-Champaign. His professional background and training are in motor control and gerontology. Dr. Sosnoff’s current research focuses on the prediction, consequences, and prevention of walking, mobility, and balance impairments in individuals with MS.
Megan R. Weigel, DNP, ARNP-c, MSCN
Baptist Neurology, Jacksonville Beach, Florida, USA
Dr. Weigel is the Immediate Past President of the International Organization of MS Nurses. She serves on the Clinical Advisory Committee for the National MS Society, North Florida Chapter, and is the co-founder of oMS Yoga, a yoga program developed for people living with MS. Her doctoral research interest was preventive health care in MS.
June Halper, MSN, ANP, FAAN
Consortium of Multiple Sclerosis Centers, Hackensack, New Jersey, USA
Charlene Belsole, CCRP
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Ohio, USA